GCEYX
Price
$17.70
Change
+$0.07 (+0.40%)
Updated
Dec 26 closing price
Net Assets
2.81B
RWICX
Price
$71.30
Change
+$0.08 (+0.11%)
Updated
Dec 26 closing price
Net Assets
142.32B
Interact to see
Advertisement

GCEYX vs RWICX

Header iconGCEYX vs RWICX Comparison
Open Charts GCEYX vs RWICXBanner chart's image
AB Global Core Equity Advisor
Price$17.70
Change+$0.07 (+0.40%)
VolumeN/A
Net Assets2.81B
American Funds Capital World Gr&Inc R3
Price$71.30
Change+$0.08 (+0.11%)
VolumeN/A
Net Assets142.32B
GCEYX vs RWICX Comparison Chart in %
View a ticker or compare two or three
VS
GCEYX vs. RWICX commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCEYX is a StrongBuy and RWICX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWICX has more cash in the bank: 142B vs. GCEYX (2.81B). RWICX pays higher dividends than GCEYX: RWICX (1.11) vs GCEYX (0.95). GCEYX was incepted earlier than RWICX: GCEYX (11 years) vs RWICX (24 years). RWICX (1.06) is less costly to investors than GCEYX (0.78). GCEYX is a more actively managed with annual turnover of: 67.00 vs. RWICX (27.00). GCEYX has a lower initial minimum investment than RWICX: GCEYX (0) vs RWICX (250). RWICX annual gain was more profitable for investors over the last year : 12.08 vs. GCEYX (3.33). RWICX return over 5 years is better than : 29.60 vs. GCEYX (21.00).
GCEYXRWICXGCEYX / RWICX
Total Expense Ratio0.781.0674%
Annual Report Gross Expense Ratio0.781.0674%
Fund Existence11 years24 years-
Gain YTD5.10714.12636%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.81B142B2%
Annual Yield % from dividends0.951.1186%
Returns for 1 year3.3312.0828%
Returns for 3 years36.5544.8582%
Returns for 5 years21.0029.6071%
Returns for 10 years91.1071.36128%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GEMPX15.140.09
+0.60%
Goldman Sachs Emerging Mkts Eq ex. Chn P
PRIDX75.330.10
+0.13%
T. Rowe Price International Discovery
RSIGX18.030.02
+0.11%
Victory RS International Y
WPGSX11.550.01
+0.09%
WPG Partners Select Small Cap Value Ins
ETIHX52.77-0.40
-0.75%
Eventide Healthcare & Life Sciences I